PG
Paul Ginocchio
Chief Financial Officer

Paul Ginocchio insider trades: Augmedix (AUGX) stock buys and sales

Chief Financial Officer, Augmedix Last trade May 15, 2024 16 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
9
Open-market trades
since 2021
2
Companies
last trade 2024

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Paul reports to the SEC

AUGX
AUGXAugmedix
Chief Financial Officer · last filing Oct 4, 2024
-$3K
+$437K
NONEAugmedix
Chief Financial Officer · last filing Jan 21, 2021
No market trades

Open-market buys and sales

9 trades reported on SEC Form 4, newest first

DateStockTypeValue
May 15, 2024AUGX↓ Sell$3K
Nov 22, 2023AUGX↑ Buy$49K
Dec 13, 2022AUGX↑ Buy$22K
May 27, 2022AUGX↑ Buy$36K
Nov 23, 2021AUGX↑ Buy$41K
Oct 28, 2021AUGX↑ Buy$136K
Jun 8, 2021AUGX↑ Buy$61K
May 25, 2021AUGX↑ Buy$43K
May 19, 2021AUGX↑ Buy$50K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Paul Ginocchio's insider trades

Paul Ginocchio is Chief Financial Officer at Augmedix (AUGX). Since May 19, 2021, Paul has reported 8 open-market purchases worth $437K and 1 sale worth $3K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (5 filings), option exercises (2 filings), shares returned to the company (1 filing), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AUGX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.